Literature DB >> 629260

Agreement rates between oral contraceptive users and prescribers in relation to drug use histories.

P D Stolley, J A Tonascia, P E Sartwell, M S Tockman, S Tonascia, A Rutledge, R Schinnar.   

Abstract

A comparison between prescriber records and patient-reported oral contraceptive histories obtained during a case-control study of thromboembolism and oral contraceptive use served as the basis for evaluating the extent of agreement between these two sources of information. Agreement between oral contraceptive user and prescriber was highest on the name of the most recently-used product (89% agreement), and dropped to 62.5% on the name of the product taken before the more recent one. For total duration of oral contraceptive use (to within one month of hospital admission), agreement (defined as differences not exceeding one month) was 36%, while 39% showed the users reporting longer duration of use, and 25% showed users reporting shorter duration. Cases showed a higher rate of agreement with prescriber records than the controls on both the name of the product and the total duration of use. Disagreement from prescriber records in the direction of reporting longer duration of use was 45% for the controls compared to 27% for the cases. These results indicate that while user information in connection with the most recently used oral contraceptive can be acceptable in studies employing the case-control research strategy, user reports about previous oral contraceptive use may be less useful.

Entities:  

Keywords:  Contraception; Contraceptive Methods; Data Collection; Family Planning; Kap; Oral Contraceptives; Psychological Factors; Research Methodology

Mesh:

Substances:

Year:  1978        PMID: 629260     DOI: 10.1093/oxfordjournals.aje.a112529

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  12 in total

1.  Recent oral contraceptive use and risk of breast cancer (United States)

Authors:  P A Newcomb; M P Longnecker; B E Storer; R Mittendorf; J Baron; R W Clapp; A Trentham-Dietz; W C Willett
Journal:  Cancer Causes Control       Date:  1996-09       Impact factor: 2.506

2.  A comparison of self-reported oral contraceptive use and automated pharmacy data in perimenopausal and early postmenopausal women.

Authors:  Leslie Spangler; Laura E Ichikawa; Rebecca A Hubbard; Belinda Operskalski; Andrea Z LaCroix; Susan M Ott; Delia Scholes
Journal:  Ann Epidemiol       Date:  2014-10-16       Impact factor: 3.797

3.  Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands.

Authors:  O H Klungel; A de Boer; A H Paes; R M Herings; J C Seidell; A Bakker
Journal:  Pharm World Sci       Date:  1999-10

4.  Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer.

Authors:  Roberta B Ness; Rhiannon C Dodge; Robert P Edwards; Julie A Baker; Kirsten B Moysich
Journal:  Ann Epidemiol       Date:  2010-12-15       Impact factor: 3.797

5.  Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.

Authors:  O Lidegaard
Journal:  BMJ       Date:  1993-04-10

6.  Comparison of prospective daily diaries and retrospective recall to measure oral contraceptive adherence.

Authors:  Larissa R Brunner Huber; Elizabeth C Broel; Ashley N Mitchelides; Jacek Dmochowski; Michael Dulin; Delia Scholes
Journal:  Contraception       Date:  2013-03-15       Impact factor: 3.375

7.  Information on drug use in the elderly: a comparison of pharmacy, general-practitioner and patient data.

Authors:  E R Heerdink; H G Leufkens; C Koppedraaijer; A Bakker
Journal:  Pharm World Sci       Date:  1995-01-27

8.  General practitioner notes as a source of information for case-control studies in young women. UK National Case-Control Study Group.

Authors:  C E Chilvers; M C Pike; C N Taylor; C Hermon; B Crossley; S J Smith
Journal:  J Epidemiol Community Health       Date:  1994-02       Impact factor: 3.710

9.  Validity of self-report of lipid medication use: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Sahiti Bhaskara; Eric A Whitsel; Christie M Ballantyne; Aaron R Folsom
Journal:  Atherosclerosis       Date:  2015-08-20       Impact factor: 5.162

10.  A comparison of interview methods to ascertain fluoroquinolone exposure before tuberculosis diagnosis.

Authors:  Y F Van Der Heijden; F Maruri; E Holt; E Mitchel; J Warkentin; T R Sterling
Journal:  Epidemiol Infect       Date:  2014-11-25       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.